The anti-Phospho-GSK3B-S21/29 antibody is used in Western blot to detect Phospho-GSK3B-S21/29 in mouse thymus tissue lysate.
GSK3B / GSK3 Beta Antibody (phospho-Ser21/Ser29)
Primary AntibodyLSBio Guarantee
| Antibody: | Rabbit Polyclonal |
| Applications: | Immunohistochemistry (general), Immunohistochemistry, Paraffin, Western Blot |
| Reactivity: | Human, Mouse |
| Format: | Liquid |
$401.00each
Catalog Number: LS-C96880-400
Catalog Number: LS-C96880
For bulk orders or custom formulations:
Request a QuoteOverview
- Description
- GSK3 Beta antibody LS-C96880 is an unconjugated rabbit polyclonal antibody to GSK3 Beta (GSK3B) (pSer21/Ser29) from human. It is reactive with human and mouse. Validated for IHC and WB. Cited in 1 publication.
- Application
- IHC, IHC-P, WB
- Reactivity
- Hu, Ms
- Intended Use
- Research Use Only
- Guarantees
- This antibody carries the LSBio 100% Guarantee. ✓
- Category
- Antibodies > Primary Antibodies > Polyclonal Antibodies
- Alternative Names
- GSK3B | GSK-3 beta | GSK3 beta | GSK3beta | GSK3beta isoform | TPKI | GSK 3beta | Tau protein kinase I | ZGSK-3beta
- Recommended Dilution: IHC-P
- 1:50 - 1:100
- Recommended Dilution: WB
- 1:1000
- UniProt Number
- P49841
- NCBI GenBank
- NM_002093 | NP_002084.2
- SwissProt
- P49841
Target
- Target
- Human GSK3B / GSK3 Beta
- Antigen Species
- Human
- Epitope
- This GSK3B Antibody is generated from rabbits immunized with a KLH conjugated synthetic phosphopeptide corresponding to amino acid residues surrounding S21/29 of human GSK3B.
- Gene Name
- GSK3B
Antibody
- Host Species
- Rabbit
- Clonality
- Polyclonal
- Origin Species
- Human
Immunogen
- Immunogen Type
- Synthetic Peptide (Linear)
Format
- Conjugate/Label
- Unconjugated
- Format
- Liquid
- Formulation
- PBS, 0.09% Sodium Azide
- Volume
- 400 Microliter
- Preservative
- Yes
- Purification Method
- Protein A Affinity
Storage & Handling
- Storage Conditions
- Maintain refrigerated at 2°C to 8°C for up to 6 months. For long term storage store at -20°C.
- Recommended Storage Buffer
- PBS
Global quantitative phosphoproteome analysis of human tumor xenografts treated with a CD44 antagonist. Weigand S, Herting F, Maisel D, Nopora A, Voss E, Schaab C, Klammer M, Tebbe A. Cancer research. 2012 Sep;72:4329-39. PubMed: 22777824